MX2014015096A - Alimento para crustaceos. - Google Patents
Alimento para crustaceos.Info
- Publication number
- MX2014015096A MX2014015096A MX2014015096A MX2014015096A MX2014015096A MX 2014015096 A MX2014015096 A MX 2014015096A MX 2014015096 A MX2014015096 A MX 2014015096A MX 2014015096 A MX2014015096 A MX 2014015096A MX 2014015096 A MX2014015096 A MX 2014015096A
- Authority
- MX
- Mexico
- Prior art keywords
- coenzyme
- crustacean
- infectious diseases
- viral infectious
- preventing
- Prior art date
Links
- 241000238424 Crustacea Species 0.000 title abstract 5
- 235000017471 coenzyme Q10 Nutrition 0.000 abstract 9
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 abstract 9
- 208000035473 Communicable disease Diseases 0.000 abstract 4
- 230000003612 virological effect Effects 0.000 abstract 4
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 2
- 230000037396 body weight Effects 0.000 abstract 2
- 229940110767 coenzyme Q10 Drugs 0.000 abstract 2
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/30—Other Organic compounds
- A23V2250/314—Ubiquinone, coenzyme Qn
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Food Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Insects & Arthropods (AREA)
- Marine Sciences & Fisheries (AREA)
- Birds (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Fodder In General (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Feed For Specific Animals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se relaciona al problema de proporcionar un método donde enfermedades de infecciones virales en crustáceos pueden ser evitadas y/o tratadas sin usar antibióticos y un alimento para prevenir y/o tratar enfermedades de infección viral. El método para prevenir y/o tratar enfermedades de infección viral en crustáceos de acuerdo a la presente invención se caracteriza por comprender administrar al crustáceo coenzima Q, la coenzima Q que contiene 50% o más de coenzima Q10 con relación a la coenzima Q total, en una dosis de 1.2-8 mg/día por kg de peso corporal. El alimento para evitar y/o tratar enfermedades de infección viral en crustáceos de acuerdo a la presente invención se caracteriza por comprender, como un ingrediente activo, 1 ppm ó más de coenzima Q, la coenzima Q que contiene 50% ó más de coenzima Q10 con relación a la coenzima Q total, y que es administrada en la forma que la coenzima Q que es el ingrediente activo es administrada en una dosis de 1.2-8 mg/día por kg de peso corporal.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012147108 | 2012-06-29 | ||
PCT/JP2013/067552 WO2014003069A1 (ja) | 2012-06-29 | 2013-06-26 | 甲殻類用飼料 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2014015096A true MX2014015096A (es) | 2015-03-05 |
Family
ID=49783210
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2014015096A MX2014015096A (es) | 2012-06-29 | 2013-06-26 | Alimento para crustaceos. |
Country Status (5)
Country | Link |
---|---|
JP (1) | JP6141841B2 (es) |
CN (1) | CN104394707A (es) |
MX (1) | MX2014015096A (es) |
MY (1) | MY169733A (es) |
WO (1) | WO2014003069A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112017002324A2 (pt) * | 2014-08-06 | 2018-01-16 | Envera Llc | composições de esporo bacteriano para usos industriais |
JPWO2019189213A1 (ja) * | 2018-03-27 | 2021-03-25 | 株式会社カネカ | 抗病性飼料、水生生物の生産方法、水生生物、及び抗病性付与方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07123928A (ja) * | 1993-11-09 | 1995-05-16 | Ajinomoto Co Inc | 家禽疾病予防剤及び家禽用飼料 |
JPH09187229A (ja) * | 1996-01-10 | 1997-07-22 | Idemitsu Material Kk | 家禽用飼料組成物 |
JP2003238396A (ja) * | 2002-02-21 | 2003-08-27 | Nisshin Pharma Inc | コエンザイムq10含有乳化組成物 |
JPWO2008156108A1 (ja) * | 2007-06-21 | 2010-08-26 | 株式会社カネカ | 機能性家畜生産品およびその製造方法 |
-
2013
- 2013-06-26 CN CN201380034786.2A patent/CN104394707A/zh active Pending
- 2013-06-26 JP JP2014522662A patent/JP6141841B2/ja active Active
- 2013-06-26 WO PCT/JP2013/067552 patent/WO2014003069A1/ja active Application Filing
- 2013-06-26 MY MYPI2014703832A patent/MY169733A/en unknown
- 2013-06-26 MX MX2014015096A patent/MX2014015096A/es unknown
Also Published As
Publication number | Publication date |
---|---|
MY169733A (en) | 2019-05-14 |
JPWO2014003069A1 (ja) | 2016-06-02 |
CN104394707A (zh) | 2015-03-04 |
JP6141841B2 (ja) | 2017-06-07 |
WO2014003069A1 (ja) | 2014-01-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ732507A (en) | Improved compositions for treating muscular dystrophy | |
MX2022003072A (es) | Uso de pridopidina para el tratamiento de la disminucion funcional. | |
EA028928B9 (ru) | 2'-замещенные карбануклеозидные аналоги для противовирусного лечения | |
NZ702663A (en) | Nuclear transport modulators and uses thereof | |
MX2019012884A (es) | Terapia de combinacion. | |
MX2022009352A (es) | Sal de hemisulfato de nucleotido para el tratamiento del virus de hepatitis c. | |
MX2014002171A (es) | Tratamientos de combinacion para hepatitis c. | |
NZ602510A (en) | Treatment of lupus nephritis using laquinimod | |
TN2012000566A1 (en) | Dry powder formulation comprising an antimuscarinic drug | |
MX345238B (es) | (aralquilamino y heteroarilalquilamino alfa-substituidos)pirimidin ilo y 1,3,5-triazinilbenzimidazoles, composiciones farmacéuticas que los contienen, y estos compuestos para su uso en el tratamiento de enfermedades proliferativas. | |
MX338554B (es) | Compuestos de fenil carbamato para usarse en aliviar o tratar el dolor. | |
MX2017003780A (es) | Composicion farmaceutica para tratar colitis ulcerativa. | |
MX2014009850A (es) | Spiro [2.4] heptanos para aplicaciones relacionadas con el tratamiento de infecciones de flaviviridae. | |
IN2012DN00857A (es) | ||
MX2017013636A (es) | Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde diferentes particulas. | |
MX2013002208A (es) | Derivados de sulfonilpiperazina que interactuan con la proteina reguladora de glucocinasa para el tratamiento de diabetes. | |
MX360409B (es) | Terapia de combinacion de dosis fija para la enfermedad de parkinson. | |
MX2013003523A (es) | Composicion farmaceutica de dosis baja. | |
EP4234021A3 (en) | Pharmaceutical composition comprising an adenosine derivative for use in the prevention or treatment of diabetic nephropathy | |
MX2014015096A (es) | Alimento para crustaceos. | |
MX2019006942A (es) | Agonistas de receptores de oxitocina no peptidicos. | |
MX2017013633A (es) | Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde particulas. | |
MY160904A (en) | Piperazines as antimalarial agents | |
JOP20170044B1 (ar) | تركيبة صيدلانية تشتمل على hgh ناتج عن عودة الارتباط الجيني لعلاج نقص هرمون النمو | |
MX2017013643A (es) | Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde particulas y una matriz. |